Lipoprotein subclass patterns in women with polycystic ovary syndrome (PCOS) compared with equally insulin-resistant women without PCOS

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 8, 2010, Pages 3933-3939

  Phelan, N ^a   O'Connor, A ^b   Kyaw Tun, T ^a   Correia, N ^a   Boran, G ^a   Roche, H M ^b   Gibney, James ^a  

^a ADELAIDE AND MEATH HOSPITAL   (Ireland)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; CHOLESTEROL; FATTY ACID; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; AGE DISTRIBUTION; ARTICLE; ATHEROGENIC DIET; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; ELECTROPHORETIC MOBILITY; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; PARTICLE SIZE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE;

EID: 77955409168     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-2444     Document Type: Article

References (41)

1. Dejager S, Pichard C, Giral P, Bruckert E, Federspield MC, Beucler I, Turpin G 2001 Smaller LDL particle size in women with polycystic ovary syndrome compared to controls. Clin Endocrinol (Oxf) 54: 455-462
2. Berneis K, Rizzo M, Lazzarini V, Lazzaroni V, Fruzzetti F, Carmina E 2007 Atherogenic lipoprotein phenotype and low-density lipoproteins size and subclasses in women with polycystic ovary syndrome. J Clin Endocrinol Metab 92:186-189
3. Berneis K, Rizzo M, Hersberger M, Rini GB, Di Fede G, Pepe I, Spinas GA, Carmina E 2009 Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome. Int J Clin Pract 63:56-62
4. Yilmaz M, Biri A, Bukan N, Karakoç A, Sancak B, Törüner F, Paşaoǧlu H 2005 Levels of lipoprotein and homocysteine in nonobese and obese patients with polycystic ovary syndrome. Gynecol Endocrinol 20:258-263
5. Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, Chrousos GP 2007 Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab 18:280-285
6. Talbott E, Clerici A, Berga SL, Kuller L, Guzick D, Detre K, Daniels T, Engberg RA 1998 Adverse lipid and coronary heart disease risk profiles in young women with polycystic ovary syndrome: results of a case-control study. J Clin Epidemiol 51:415-422
7. Zeljkovic A, Vekic J, Spasojevic-Kalimanovska V, Jelic-Ivanovic Z, Bogavac-Stanojevic N, Gulan B, Spasic S LDL and HDL subclasses in acute ischemic stroke: prediction of risk and short-term mortality. Atherosclerosis doi: 10.1016/j.atherosclerosis.2009.11.040
8. Koba S, Yokota Y, Hirano T, Ito Y, Ban Y, Tsunoda F, Sato T, Shoji M, Suzuki H, Geshi E, Kobayashi Y, Katagiri T 2008 Small LDL-cholesterol is superior to LDL-cholesterol for determining severe coronary atherosclerosis. J Atheroscler Thromb 15:250-260
9. Rizzo M, Pernice V, Frasheri A, Di Lorenzo G, Rini GB, Spinas GA, Berneis K 2009 Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome. Clin Endocrinol (Oxf) 70:870-875
10. Taskinen MR 2003 LDL-cholesterol, HDL-cholesterol or triglycerides - which is the culprit? Diabetes Res Clin Pract 61(Suppl 1): S19-S26
11. Koba S, Hirano T, Ito Y, Tsunoda F, Yokota Y, Ban Y, Iso Y, Suzuki H, Katagiri T 2006 Significance of small dense low-density lipoprotein- cholesterol concentrations in relation to the severity of coronary heart diseases. Atherosclerosis 189:206-214
12. Moon JY, Kwon HM, Kwon SW, Yoon SJ, Kim JS, Lee SJ, Park JK, Rhee JH, Yoon YW, Hong BK, Rim SJ, Kim HS 2007 Lipoprotein(a) and LDL particle size are related to the severity of coronary artery disease. Cardiology 108:282-289
13. Zambon A, Hokanson JE 1998 Lipoprotein classes and coronary disease regression. Curr Opin Lipidol 9:329-336
14. Galluzzo A, Amato MC, Giordano C 2008 Insulin resistance and polycystic ovary syndrome. Nutr Metab Cardiovasc Dis 18:511-518
15. Wang Y, Qu J, Wu X, Hou L, Erkkola R 2010 Different phenotypes of polycystic ovary syndrome by Rotterdam criteria are differently steroidogenic but similarly insulin resistant. Fertil Steril 93:1362-1365
16. Svendsen PF, Madsbad S, Nilas L The insulin-resistant phenotype of polycystic ovary syndrome. Fertil Steril doi: 10.1016/j.fertnstert. 2009.04.008
17. Shumak SL 2009 Even lean women with PCOS are insulin resistant. BMJ 338:b954
18. Roa Barrios M, Arata-Bellabarba G, Valeri L, Velázquez-Maldonado E 2009 [Relationship between the triglyceride/high-density lipoprotein- cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome]. Endocrinol Nutr 56:59-65
19. Robinson S, Henderson AD, Gelding SV, Kiddy D, Niththyananthan R, Bush A, Richmond W, Johnston DG, Franks S 1996 Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries. Clin Endocrinol (Oxf) 44:277-284 (Pubitemid 26063404)
20. Avignon A, Boegner C, Mariano-Goulart D, Colette C, Monnier L 1999 Assessment of insulin sensitivity from plasma insulin and glucose in the fasting or post oral glucose-load state. Int J Obes Relat Metab Disord 23:512-517
21. Ciampelli M, Leoni F, Cucinelli F, Mancuso S, Panunzi S, De Gaetano A, Lanzone A 2005 Assessment of insulin sensitivity from measurements in the fasting state and during an oral glucose tolerance test in polycystic ovary syndrome and menopausal patients. J Clin Endocrinol Metab 90:1398-1406
22. Hoefner DM, Hodel SD, O'Brien JF, Branum EL, Sun D, Meissner I, McConnell JP 2001 Development of a rapid, quantitative method for LDL subfractionation with use of the Quantimetrix Lipoprint LDL System. Clin Chem 47:266-274
23. Zawadzki J, Dunaif A 1992 Diagnostic criteria for polycystic ovary syndrome: towards a rational approach. Haseltine F, Merriam G, eds. Boston: Blackwell Scientific
24. Baecke JA, Burema J, Frijters JE 1982 A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 36:936-942
25. Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, Neubauer G, Klibanski A 2004 Measurement of free testosterone in normal women and women with androgen deficiency: comparison of methods. J Clin Endocrinol Metab 89:525-533
26. Vermeulen A, Verdonck L, Kaufman JM 1999 A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 84:3666-3672
27. Dobiásová M, Frohlich J 2000 [The new atherogenic plasma index reflects the triglyceride and HDL-cholesterol ratio, the lipoprotein particle size and the cholesterol esterification rate: changes during lipanor therapy]. Vnitr Lek 46:152-156
28. Dobiásová M, Frohlich J 2001 The plasma parameter log (TG/ HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma [FER(HDL)]. Clin Biochem 34:583-588
29. Dobiásová M 2006 [AIP - atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice]. Vnitr Lek 52:64-71
30. Macut D, Panidis D, Glisić B, Spanos N, Petakov M, Bjekić J, Stanojlović O, Rousso D, Kourtis A, Bozić I, Damjanović S 2008 Lipid and lipoprotein profile in women with polycystic ovary syndrome. Can J Physiol Pharmacol 86:199-204
31. Pirwany IR, Fleming R, Greer IA, Packard CJ, Sattar N 2001 Lipids and lipoprotein subfractions in women with PCOS: relationship to metabolic and endocrine parameters. Clin Endocrinol (Oxf) 54:447-453
32. Doi SA, Abbas JM, Parkinson L, Chakraborty J, Akanji AO 2008 LDL species heterogeneity in the atherogenic dyslipidemia of polycystic ovary syndrome. Am J Clin Pathol 129:802-810
33. Packard CJ 2003 Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Biochem Soc Trans 31(Pt 5):1066-1069
34. Tsompanidi EM, Brinkmeier MS, Fotiadou EH, Giakoumi SM, Kypreos KE 2010 HDL biogenesis and functions: role of HDL quality and quantity in atherosclerosis. Atherosclerosis 208:3-9
35. Hajer GR, van der Graaf Y, Bots ML, Algra A, Visseren FL 2009 Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c. Eur J Clin Invest 39:680-688
36. Griffin BA, Freeman DJ, Tait GW, Thomson J, Caslake MJ, Packard CJ, Shepherd J 1994 Role of plasma triglyceride in the regulation of plasma low density lipoprotein (LDL) subfractions: relative contribution of small, dense LDL to coronary heart disease risk. Atherosclerosis 106:241-253
37. James RW, Brulhart-Meynet MC, Lehmann T, Golay A 1997 Lipoprotein distribution and composition in obesity: their association with central adiposity. Int J Obes Relat Metab Disord 21:1115-1120
38. Gormsen LC, Nellemann B, Sørensen LP, Jensen MD, Christiansen JS, Nielsen S 2009 Impact of body composition on very-low-density lipoprotein-triglycerides kinetics. Am J Physiol Endocrinol Metab 296:E165-E173
39. Maliqueo M, Sir-Petermann T, Pérez V, Echiburú B, de Guevara AL, Gálvez C, Crisosto N, Azziz R 2009 Adrenal function during childhood and puberty in daughters of women with polycystic ovary syndrome. J Clin Endocrinol Metab 94:3282-3288
40. Cortón M, Botella-Carretero JI, Benguría A, Villuendas G, Zaballos A, San Millán JL, Escobar-Morreale HF, Peral B 2007 Differential gene expression profile in omental adipose tissue in women with polycystic ovary syndrome. J Clin Endocrinol Metab 92:328-337
41. Cortón M, Botella-Carretero JI, López JA, Camafeita E, San Millán JL, Escobar-Morreale HF, Peral B 2008 Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry. Hum Reprod 23:651-361